Cooper Pharma Introduces T3BOLIC (Levothyroxine Tablets BP 50 mcg)

SHAKTI NAGAR, India - Feb. 6, 2018 - PRLog -- Cooper Pharma is a leader in generic/hormones drugs in India and has introduced new molecules to help address patients' needs.

we has launched a new hormones product of T3BOLIC (Levothyroxine Tablets BP 50 mcg) used for treat hypothyroidism. This is a condition when your thyroid gland produces too little thyroid hormone. T3BOLIC (Levothyroxine) also can be used to treat goiter, which is an enlarged thyroid gland. It also treats certain types of thyroid cancer.

How it works

T3BOLIC (Levothyroxine) belongs to a class of drugs called hormones. A class of drugs is a group of medications that work in a similar way. These drugs are often used to treat similar conditions. Levothyroxine works by providing the thyroid hormone that your thyroid gland would produce if it were working normally.

Indications:
Levothyroxine sodium is used for the treatment of thyroid deficiency states.
Dosage & Administration:
The dose of levothyroxine should be individualised on the basis of clinical response and biochemical tests, and should be monitored regularly to
avoid both undertreatment and overtreatment.
Adults:
Initially, 50 to 100 micrograms daily (two to four tablets daily), preferably taken before breakfast or your first meal of the day. Adjust at three to
four week intervals by 50 micrograms until normal metabolism is steadily maintained. The final dose may be up to 100 to 200 micrograms.
Elderly: as for patients aged over 50 years
For patients over 50 years, initially, it is not advisable to exceed 50 micrograms daily. In this condition, the daily dose may be increased by 50
micrograms at intervals of every 3-4 weeks, until stable thyroxine levels are attained. The final daily dose may be up to 50 to 200 micrograms.

Patients over 50 years with cardiac disease:
Where there is cardiac disease, 25 micrograms daily or 50 micrograms on alternate days is more suitable. In this condition, the daily dosage may be
increased by 25 microgram increments at intervals of every 4 weeks, until stable thyroxine levels are attained. The final daily dose may be up to 50
to 200 micrograms.
For patients aged over 50 years, with or without cardiac disease, clinical response is probably a more acceptable criteria of dosage rather that serum
levels.
Paediatric patients:
The maintenance dose is generally 100 to 150 micrograms per m2 body surface area. The dose for children depends on their age, weight and the
condition being treated.
Congenital hypothyroidism in infants:
For neonates and infants with congenital hypothyroidism, where rapid replacement is important, the initial recommended dosage is 10 to 15
micrograms per kg body weight per day for the first three months. Thereafter, the dose should be adjusted individually according to the clinical
findings and thyroid hormone and TSH values.
Acquired hypothyroidism in children:
For children with acquired hypothyroidism, the initial recommended dosage is 12.5-50 micrograms per day. The dose should be increased gradually
every two to four weeks according to the clinical findings and thyroid hormone and TSH values until the full replacement dose is reached.
Infants should be given the total daily dose at least half an hour before the first meal of the day.

For More Details Please Contact us on our website :- https://www.cooperpharma.com